| Expression |
Category |
Term |
Count |
% |
P Value |
| up-regulated |
GOTERM_BP_DIRECT |
GO:0007067~mitotic nuclear division |
18 |
38.29787234 |
1.28E-20 |
|
GOTERM_BP_DIRECT |
GO:0051301~cell division |
17 |
36.17021277 |
1.39E-16 |
|
GOTERM_BP_DIRECT |
GO:0007062~sister chromatid cohesion |
9 |
19.14893617 |
1.85E-10 |
|
GOTERM_BP_DIRECT |
GO:0000086~G2/M transition of mitotic cell cycle |
9 |
19.14893617 |
1.82E-09 |
|
GOTERM_BP_DIRECT |
GO:0007059~chromosome segregation |
7 |
14.89361702 |
1.91E-08 |
|
GOTERM_CC_DIRECT |
GO:0005819~spindle |
11 |
23.40425532 |
2.99E-13 |
|
GOTERM_CC_DIRECT |
GO:0030496~midbody |
10 |
21.27659574 |
2.40E-11 |
|
GOTERM_CC_DIRECT |
GO:0005874~microtubule |
11 |
23.40425532 |
3.41E-09 |
|
GOTERM_CC_DIRECT |
GO:0000775~chromosome, centromeric region |
7 |
14.89361702 |
5.29E-09 |
|
GOTERM_CC_DIRECT |
GO:0000776~kinetochore |
7 |
14.89361702 |
4.53E-08 |
|
GOTERM_MF_DIRECT |
GO:0005515~protein binding |
41 |
87.23404255 |
9.05E-10 |
|
GOTERM_MF_DIRECT |
GO:0005524~ATP binding |
18 |
38.29787234 |
3.45E-08 |
|
GOTERM_MF_DIRECT |
GO:0003777~microtubule motor activity |
7 |
14.89361702 |
4.29E-08 |
|
GOTERM_MF_DIRECT |
GO:0008017~microtubule binding |
8 |
17.0212766 |
7.29E-07 |
|
GOTERM_MF_DIRECT |
GO:0004674~protein serine/threonine kinase activity |
8 |
17.0212766 |
3.54E-05 |
|
KEGG_PATHWAY |
hsa04110:Cell cycle |
6 |
12.76595745 |
1.97E-06 |
|
KEGG_PATHWAY |
hsa04114:Oocyte meiosis |
4 |
8.510638298 |
9.73E-04 |
|
KEGG_PATHWAY |
hsa04115:p53 signaling pathway |
3 |
6.382978723 |
0.00674313 |
|
KEGG_PATHWAY |
hsa04914:Progesterone-mediated oocyte maturation |
3 |
6.382978723 |
0.01117001 |
|
KEGG_PATHWAY |
hsa05203:Viral carcinogenesis |
3 |
6.382978723 |
0.05510903 |
| down-regulated |
GOTERM_BP_DIRECT |
GO:0007268~chemical synaptic transmission |
16 |
14.15929204 |
1.58E-11 |
|
GOTERM_BP_DIRECT |
GO:0007269~neurotransmitter secretion |
6 |
5.309734513 |
1.41E-05 |
|
GOTERM_BP_DIRECT |
GO:0006836~neurotransmitter transport |
5 |
4.424778761 |
1.73E-05 |
|
GOTERM_BP_DIRECT |
GO:1902476~chloride transmembrane transport |
7 |
6.194690265 |
2.15E-05 |
|
GOTERM_BP_DIRECT |
GO:0006811~ion transport |
7 |
6.194690265 |
1.24E-04 |
|
GOTERM_CC_DIRECT |
GO:0030054~cell junction |
25 |
22.12389381 |
1.97E-16 |
|
GOTERM_CC_DIRECT |
GO:0030672~synaptic vesicle membrane |
10 |
8.849557522 |
3.25E-11 |
|
GOTERM_CC_DIRECT |
GO:0005886~plasma membrane |
52 |
46.01769912 |
1.47E-08 |
|
GOTERM_CC_DIRECT |
GO:0048786~presynaptic active zone |
6 |
5.309734513 |
7.06E-07 |
|
GOTERM_CC_DIRECT |
GO:0008021~synaptic vesicle |
8 |
7.079646018 |
1.22E-06 |
|
GOTERM_MF_DIRECT |
GO:0004890~GABA-A receptor activity |
4 |
3.539823009 |
1.88E-04 |
|
GOTERM_MF_DIRECT |
GO:0005509~calcium ion binding |
14 |
12.38938053 |
3.42E-04 |
|
GOTERM_MF_DIRECT |
GO:0005230~extracellular ligand-gated ion channel activity |
4 |
3.539823009 |
9.96E-04 |
|
GOTERM_MF_DIRECT |
GO:0044325~ion channel binding |
5 |
4.424778761 |
0.00472253 |
|
GOTERM_MF_DIRECT |
GO:0048306~calcium-dependent protein binding |
4 |
3.539823009 |
0.00505404 |
|
KEGG_PATHWAY |
hsa05033:Nicotine addiction |
7 |
6.194690265 |
2.30E-07 |
|
KEGG_PATHWAY |
hsa04723:Retrograde endocannabinoid signaling |
9 |
7.96460177 |
3.09E-07 |
|
KEGG_PATHWAY |
hsa04727:GABAergic synapse |
8 |
7.079646018 |
1.40E-06 |
|
KEGG_PATHWAY |
hsa05032:Morphine addiction |
7 |
6.194690265 |
3.07E-05 |
|
KEGG_PATHWAY |
hsa04721:Synaptic vesicle cycle |
6 |
5.309734513 |
6.13E-05 |
